Our program has active clinical trials in acute pancreatitis, pancreatic cystic disorders, pancreatic genetic disorders, and other conditions involving the pancreas. These studies are supported by the National Institute of Health (NIH) and other resources.
Highlights of two current trials focused on the following questions:
- Will The Acute Pancreatitis Early Response (TAPER)–Clinical Decision Support (CDS)–Tool increase compliance with accepted clinical guidelines, improve clinical outcomes, and lower hospitalization costs for patients with acute pancreatitis?
- Can specialized imaging software (analytic morphomics) more accurately classify the type pancreatic cysts (low versus higher risk for cancer) to promote a personalized approach to monitoring and treatment.
Highlights of two past trials:
- A landmark study in which rectal indomethacin reduced the risk of acute pancreatitis in patients undergoing endoscopic retrograde cholangiopancreatography (clinicaltrials.gov/ct2/show/NCT00820612).
- A clinical trial in chronic pancreatitis showed that the diabetic medication pioglitazone improved some components of pancreatic endocrine function in this condition (clinicaltrials.gov/ct2/show/results/NCT00782795).
To learn more, visit umhealthresearch.org.